HEMORRHAGIC SHOCK TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION Hemorrhagic Shock Treatment Market - Overview Global Hemorrhagic Shock Treatment Market, by Drug (NVX-408, YW-356, LB-1148, Neutrolide, and Others), by Distribution Channel(Hospital Pharmacy, Retail Pharmacy, and Online Channels), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 175.4 million in 2020 and is expected to exhibit a CAGR of 4.0% during the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights. The growing focus of market players on research & development, the rising number of drug approvals, and introduction of approved drugs in the market is expected to favor growth of the global hemorrhagic shock treatment market. Moreover, companies are focused on strategic licensing agreements and collaborations for development of novel therapies. For instance, in January 2017, Jiangsu Nhwa Pharmaceutical and NuvOx Pharma LLC entered a licensing agreement to develop NVX-408 in China for perioperative blood loss and hemorrhagic shock treatment. NVX-408 is injected intravenously and is an oxygen therapeutic that flows through the lungs and collects oxygen and releases it after flowing through the blood and hypoxic tissue. The drug can improve survival rate during severe blood loss. The COVID-19 outbreak has adversely affected the growth of the hemorrhagic shock treatment market as challenges faced during research and development activities. Browse Research Reports: https://www.coherentmarketinsights.com/market-insight/gccmedical-gloves-market-4116 Š Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION In February 2017, the USAISR (U.S. Army Institute of Surgical Research) received FDA clearance for its hemorrhagic shock device. The researchers of USAISR collaborated with engineers and scientists at the University of Colorado and Flashback Technologies Inc., to develop an algorithm to detect when a patient is going into hemorrhagic shock. The device is the first medical monitoring technology capable of early detection of impending circulatory shock in trauma patients. Hemorrhagic Shock Treatment Market - Impact of Coronavirus (Covid-19) Pandemic The ongoing COVID-19 pandemic is preventing healthcare facilities from favorably managing COVID-19 patients and delaying other medical emergencies such as accidents and other chronic disease cases. According to the World Health Organization (WHO), 94% of the countries’ Ministry of Health staff working in the area of non-communicable diseases (NCDs) such as Parkinson’s disease, strokes, diabetes, Alzheimer’s disease, and others were fully or partially reassigned to support COVID-19. Browse 24 Market Data Tables and 30 Figures spread through 155 Pages and in-depth TOC on Global Hemorrhagic Shock Treatment Market, By Drug (NVX-408, YW-356, LB-1148, Neutrolide, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channels), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Forecast to 2027“ Request a Sample copy of this reports : https://www.coherentmarketinsights.com/insight/request-sample/4097 © Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION The increasing funding for research & development of treatment and therapies is a major factor propelling the growth of the global hemorrhagic shock treatment market. Additionally, researchers are focused on development of various hemorrhagic shock treatments. For instance, in October 2019, scientists at the Feinstein Institutes for Medical Research (FIMR) completed a study involving bio-electronic medicine strategies for hemorrhagic shock treatment. Key Takeaways of the Global Hemorrhagic Shock Treatment Market: The hemorrhagic shock treatment market is expected to exhibit a CAGR of 4.0% during the forecast period (2020-2027) owing to a surge in research & development of novel therapies and treatments for hemorrhagic shock. Among distribution channels, the hospital pharmacy segment is expected to hold the largest revenue share in the market in 2027 owing to the rising cases of trauma injuries and hemorrhagic shock. For instance, according to the National Trauma Institute, hemorrhagic shock is the second leading cause of death due to traumatic injuries.
Major players operating in the global hemorrhagic shock treatment market are Biomedica Management Corporation, NuvOx Pharma LLC, Leading BioSciences, Inc., F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Johnson & Johnson Services Inc, AstraZeneca, Daiichi Sankyo Company, Limited, Teva Pharmaceutical Industries Ltd, Novartis AG, ZydusCadila, and Amneal Pharmaceuticals LLC.
Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/4097 Š Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele.
SERVICES INDUSTRY ANALYSIS
CUSTOMIZED RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC STUDIES
Š Coherent market Insights. All Rights Reserved
ABOUT CMI SECTOR COVERAGE
BIOTECHNOLOGY
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL DEVICES
MEDICAL IMAGING
PHARMACEUTICAL
OUR CLIENTS
Global Leading Equipment and System Manufacturers Marketing Consultancies and the Advertising Industry Component Providers and System Integrators
Private and Government organization
Distributors, Retailors and Value Added Resellers
Outsourcing Companies
Healthcare IT Solutions Developers
Universities and Business Schools.
© Coherent market Insights. All Rights Reserved
KEY STATS
RESEARCH SOLUTIONS
100+
FEASIBILITY STUDIES
Insights Published Per Year
GLOBAL REPORTS
150+
Consulting Projects Till Date
COUNTRY ANALYSIS CONSULT PROJECTS
125+
Clients Worldwide Per Year
110+
SURVEY RESEARCH
EXCEL FORECAST DATABASE
CUSTOMIZED SOLUTIONS
COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved
THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702
Š Coherent market Insights. All Rights Reserved